Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Nathalie Baize, I. Monnet, Laurent Greillier, Margaux Geier, H. Léna, Henri Janicot, A. Vergnenègre, Jacky Créquit, R. Lamy, J.B. Auliac, J. Letreut, H. Le Caer, Radj Gervais, Éric Dansin, Anne Madroszyk, P Renault, G. Le Garff, L. Falchero, H. Bérard, Roland Schött, Patrick Saulnier, C. Chouaïd
Topics & Concepts
TopotecanCarboplatinMedicineEtoposideOpen labelOncologyLung cancerSecond line treatmentInternal medicineClinical trialSurgeryChemotherapyCisplatinLung Cancer Research StudiesLung Cancer Treatments and MutationsNeuroendocrine Tumor Research Advances